• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Newsletters » The Carlat Hospital Psychiatry Report
carlat-hospital-header.png

The Carlat Hospital Psychiatry Report

Substance Use Disorders (January/February/March) | 2024

View Archived Issues

Learning Objectives, Substance Use Disorders, CHPR, January/February/March 2024

January 31, 2024

After reading these articles, you should be able to...

Read More

Wernicke’s Encephalopathy and Korsakoff’s Syndrome

February 1, 2024
David C. Fipps, DO and Shirshendu Sinha, MBBS, MD

Wernicke’s encephalopathy arises from thiamine (vitamin B1) deficiency and can evolve into Korsakoff's syndrome, marked by memory deficits and confabulation. Timely detection is key to halting the progression of symptoms. Here: A guide to what signs to watch for and how to treat this disorder.

Read More

Substance-Induced Psychosis: Diagnostic Dilemmas and Treatment Options

January 31, 2024
Nicholas Athanasiou, MD, MBA, DFASAM

Substance-induced psychosis (SIP) presents diagnostic challenges in distinguishing it from primary psychotic disorders, with substance timing, symptom type, and duration being key differentiators. Effective treatment combines antipsychotic medications and substance cessation strategies. Dr. Athanasiou reviews key points in the management of SIP.

Read More

Alcohol Withdrawal: What to Watch For on the Psychiatric Inpatient Unit

January 31, 2024
Caridad Ponce Martinez, MD, FAPA, FASAM

Dr. Ponce Martinez highlights the need to identify and manage alcohol withdrawal in psychiatric settings, underscoring the use of the CIWA-Ar scale for monitoring symptom progression. While benzodiazepines remain the primary treatment, she reviews alternative treatment strategies and tells us which patients are so high risk that they must be transferred to a medical unit for care.

Read More

Inpatient Use of Benzodiazepines for Patients With Substance Use Disorders

January 31, 2024
Audrey Abelleira, PharmD, BCPP

Benzodiazepines are highly beneficial for managing anxiety and agitation in psychiatric inpatient settings, but we must be cautious about prescribing them to patients with substance use disorders (SUDs). Here we review strategies to reduce the risk of benzodiazepine misuse and discuss alternative medication options, including second-generation antipsychotics, antidepressants, gabapentin, and pregabalin.

Read More

Sublingual Dexmedetomidine for Acute Agitation in Bipolar Disorder

January 31, 2024
Sébastien Hardy, PharmD, BCPS.

Sublingual dexmedetomidine was found to work effectively and quickly for mild to moderate agitation in patients with bipolar disorder.

Read More

Are Individuals With Major Depressive Symptoms More Likely to Own a Gun in the United States?

January 31, 2024
Susan Siegfreid, MD.

A survey of gun ownership and gun purchasing plans found that individuals with depressive symptoms were significantly more likely to purchase a gun, or plan to purchase a gun, compared to non-depressed individuals, especially during the COVID-19 pandemic.

Read More

Initiation of Gender-Affirming Hormones and Mental Health Outcomes

January 31, 2024
Erin Conklin, MSN, CNP, PMHNP-BC

A study on gender-affirming hormones in adolescents and adults found they are linked to better mental health in transgender people, leading to reduced psychological distress and suicidal thoughts. The findings reinforce the Endocrine Society's advice to provide transgender adolescents with access to GAH.

Read More

CME Post-Test, Substance Use Disorders, CHPR, January/February/March 2024

January 31, 2024

By successfully completing the test you will be awarded a certificate for 2 CME credit.

Read More
SUBSCRIBE NOW
DOWNLOAD NOW
Editor-in-Chief
Hendrick.png
Victoria Hendrick, MD
Dr. Hendrick is a clinical professor at the David Geffen School of Medicine at UCLA and is the director of inpatient psychiatry at Olive View—UCLA Medical Center, where she carries a caseload of patients and provides teaching and supervision for medical students and psychiatry residents. After completing medical school and psychiatric residency at UCLA, she spent several years working as a principal investigator and co-investigator on N.I.M.H. funded research studies. She has authored or co-authored over 75 research papers, editorials, books and other publications. She has a long-standing interest in the needs of severely mentally ill patients from underserved populations and has worked in community mental health settings her entire career.
Full Editorial Information
Featured Book
  • MFB7e_Print_App_Access.png

    Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

    The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.